High‐efficient bacterial production of human ApoA‐I amyloidogenic variants
- 15 November 2018
- journal article
- research article
- Published by Wiley in Protein Science
- Vol. 27 (12) , 2101-2109
Abstract
Apolipoprotein A‐I (ApoA‐I)‐related amyloidosis is a rare disease caused by missense mutations in the APOA1 gene. These mutations lead to protein aggregation and abnormal accumulation of ApoA‐I amyloid fibrils in heart, liver, kidneys, skin, nerves, ovaries, or testes. Consequently, the carriers are at risk of single‐ or multi‐organ failure and of need of organ transplantation. Understanding the basic molecular structure and function of ApoA‐I amyloidogenic variants, as well as their biological effects, is, therefore, of great interest. However, the intrinsic low stability of this type of proteins makes their overexpression and purification difficult. To overcome this barrier, we here describe an optimized production and purification procedure for human ApoA‐I amyloidogenic proteins that efficiently provides between 46 mg and 91 mg (depending on the protein variant) of pure protein per liter of Escherichia coli culture. Structural integrity of the amyloidogenic and native ApoA‐I proteins were verified by circular dichroism spectroscopy and intrinsic fluorescence analysis, and preserved functionality was demonstrated by use of a lipid clearance assay as well as by reconstitution of high‐density lipoprotein (HDL) particles. In conclusion, the use of the described high‐yield protein production system to obtain amyloidogenic ApoA‐I proteins, and their native counterpart, will enable molecular and cellular experimental studies aimed to explain the molecular basis for this rare disease.Keywords
Funding Information
- Lunds Universitet
- Stiftelsen för Strategisk Forskning (IRC15‐0067)
- Crafoordska Stiftelsen
- Kungliga Fysiografiska Sällskapet i Lund
- Vetenskapsrådet (2009‐1039, K2014‐54X‐22426‐01‐3)
This publication has 33 references indexed in Scilit:
- The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrilsJournal of Lipid Research, 2012
- Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-IThe American Journal of Pathology, 2011
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- The metabolism and anti-atherogenic properties of HDLJournal of Lipid Research, 2009
- Mapping the Structural Transition in an Amyloidogenic Apolipoprotein A-IBiochemistry, 2007
- Structure, function and amyloidogenic propensity of apolipoprotein A-IAmyloid, 2006
- Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structureProtein Science, 2001
- Apolipoprotein AI and Transthyretin as Components of Amyloid Fibrils in a Kindred with apoAI Leu178His AmyloidosisThe American Journal of Pathology, 2000
- A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathyGenomics, 1990
- Characterization of discoidal complexes of phosphatidylcholine, apolipoprotein A-I and cholesterol by gradient gel electrophoresisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983